Overview
Ravi Mahadeva practices in Cambridge, United Kingdom. Mr. Mahadeva is rated as an Advanced expert by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Emphysema, Subcutaneous Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), and Chronic Obstructive Pulmonary Disease (COPD).
His clinical research consists of co-authoring 43 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles and participated in 1 clinical trial in the study of Alpha-1 Antitrypsin Deficiency (AATD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EmphysemaMr. Mahadeva isElite. Learn about Emphysema.
- Advanced
- Alpha-1 Antitrypsin Deficiency (AATD)Mr. Mahadeva isAdvanced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- Chronic Obstructive Pulmonary Disease (COPD)
- Subcutaneous EmphysemaMr. Mahadeva isAdvanced. Learn about Subcutaneous Emphysema.
- Experienced
- CirrhosisMr. Mahadeva isExperienced. Learn about Cirrhosis.
- Myoclonic EpilepsyMr. Mahadeva isExperienced. Learn about Myoclonic Epilepsy.